These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9253958)

  • 21. Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes.
    Joyce DA; Gibbons DP; Green P; Steer JH; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Nov; 24(11):2699-705. PubMed ID: 7957562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors.
    Priller J; Briley EM; Mansouri J; Devane WA; Mackie K; Felder CC
    Mol Pharmacol; 1995 Aug; 48(2):288-92. PubMed ID: 7651362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anandamide activates human platelets through a pathway independent of the arachidonate cascade.
    Maccarrone M; Bari M; Menichelli A; Del Principe D; Agrò AF
    FEBS Lett; 1999 Mar; 447(2-3):277-82. PubMed ID: 10214961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SR 141716A after acute or chronic cannabinoid administration in dogs.
    Lichtman AH; Wiley JL; LaVecchia KL; Neviaser ST; Arthur DB; Wilson DM; Martin BR
    Eur J Pharmacol; 1998 Sep; 357(2-3):139-48. PubMed ID: 9797029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists.
    Fleming I; Schermer B; Popp R; Busse R
    Br J Pharmacol; 1999 Feb; 126(4):949-60. PubMed ID: 10193775
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delta9-tetrahydrocannabinol and endogenous cannabinoid anandamide directly potentiate the function of glycine receptors.
    Hejazi N; Zhou C; Oz M; Sun H; Ye JH; Zhang L
    Mol Pharmacol; 2006 Mar; 69(3):991-7. PubMed ID: 16332990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages.
    Di Marzo V; De Petrocellis L; Bisogno T; Maurelli S
    Adv Exp Med Biol; 1997; 407():341-6. PubMed ID: 9321974
    [No Abstract]   [Full Text] [Related]  

  • 29. 'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors. Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism.
    Smart D; Jonsson KO; Vandevoorde S; Lambert DM; Fowler CJ
    Br J Pharmacol; 2002 Jun; 136(3):452-8. PubMed ID: 12023948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arachidonic acid release and prostaglandin F(2alpha) formation induced by anandamide and capsaicin in PC12 cells.
    Someya A; Horie S; Murayama T
    Eur J Pharmacol; 2002 Aug; 450(2):131-9. PubMed ID: 12206851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects.
    Wiley JL; Dewey MA; Jefferson RG; Winckler RL; Bridgen DT; Willoughby KA; Martin BR
    Life Sci; 2000 Aug; 67(13):1573-83. PubMed ID: 10983852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observational analysis of feeding induced by Delta9-THC and anandamide.
    Williams CM; Kirkham TC
    Physiol Behav; 2002 Jun; 76(2):241-50. PubMed ID: 12044596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of the peroxisome proliferator-activated receptor (PPAR) alpha in vascular response of endocannabinoids in the bovine ophthalmic artery.
    Romano MR; Lograno MD
    Eur J Pharmacol; 2012 May; 683(1-3):197-203. PubMed ID: 22429572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.
    Fowler CJ; Jonsson KO; Andersson A; Juntunen J; Järvinen T; Vandevoorde S; Lambert DM; Jerman JC; Smart D
    Biochem Pharmacol; 2003 Sep; 66(5):757-67. PubMed ID: 12948856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes.
    Devane WA; Axelrod J
    Proc Natl Acad Sci U S A; 1994 Jul; 91(14):6698-701. PubMed ID: 8022836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparisons of Δ9-Tetrahydrocannabinol and Anandamide on a Battery of Cognition-Related Behavior in Nonhuman Primates.
    Kangas BD; Leonard MZ; Shukla VG; Alapafuja SO; Nikas SP; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2016 Apr; 357(1):125-33. PubMed ID: 26826191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M; Scherma M; Tanda G; Wertheim CE; Fratta W; Goldberg SR
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1127-34. PubMed ID: 17351107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.
    Anikwue R; Huffman JW; Martin ZL; Welch SP
    J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro.
    Watzl B; Scuderi P; Watson RR
    Int J Immunopharmacol; 1991; 13(8):1091-7. PubMed ID: 1667651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.